PCI-32765: Interim Phase Ib/II data

Interim data from 61 patients in the open-label, U.S. Phase Ib/II PCYC-1102-CA trial showed that once-daily 420 and 840

Read the full 190 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE